UFC 244: Nate Diaz Cleared to Fight, Following Atypical Finding in Drug Test
By FCF Staff
After Nate Diaz reported that a pre-fight drug test he had taken had been flagged, the United States Anti-Doping Agency (USADA) has ruled no violation has occurred.
Earlier this week Diaz said he was no longer going to New York City for his bout with Jorge Masvidal, as a result of a drug test result. Diaz denied knowingly taking any type of performance-enhancing drug.
Now it’s been reported the fighter tested positive for trace amounts of LGD-4033, and that the atypical finding has been connected to an organic, multivitamin Diaz was taking.
A report from ESPN included the following statement from the UFC:
“Mr. Diaz has not committed an anti-doping policy violation, has not been provisionally suspended and is not subject to any sanctions. Additionally, UFC has been informed by independent experts who have determined that there is unequivocally no appreciable performance enhancing or therapeutic benefit from the significantly limited amount of LGD-4033 that may be present in his system, which is roughly 10,000 times lower than one LGD-4033 therapeutic dose.”
Diaz – Masvidal will headline the November 2nd, UFC 244 card, which will take place at Madison Square Garden.